Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00876941 · ClinicalTrials.gov registry record · Phase 3
Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use
A Phase 3 study of Drug Abuse and Drug Dependence, sponsored by Boston Medical Center.
- Completed
- Registry status
- Phase 3
- Development phase
- 589
- Enrollment target
- 1
- Study location
NCT00876941: Completed Phase 3 study of Drug Abuse and Drug Dependence, sponsored by Boston Medical Center.
NCT00876941 is a Phase 3 study of Drug Abuse and Drug Dependence that has completed, run by Boston Medical Center. The registered enrollment target is 589 participants, above the 298-participant average among 21 other Drug Abuse trials with a reported enrollment target (98% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00876941, a Phase 3 study of Drug Abuse and Drug Dependence, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 589 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to test whether screening and brief intervention for drug use among primary care patients leads to improved drug-related outcomes (such as decreased drug use and consequences).
Conditions Studied
Interventions
- BEHAVIORAL Standard Brief Intervention
- BEHAVIORAL Enhanced Brief Intervention
- BEHAVIORAL Control: Information and Feedback
Study Locations (1)
Massachusetts
- Boston Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 589 participants |
| Start Date | 2009-04 |
| Est. Completion | 2014-09 |
| Phase | Phase 3 |
What the finished NCT00876941 record still lists
NCT00876941 is an interventional study that assigns participants to a tested intervention. The registered 589 participants enrollment target is mid-sized for trials with a published cap, above the 298-participant average among 21 other Drug Abuse trials with a reported enrollment target (98% higher).
The record links to 3 conditions, with Drug Abuse appearing as the primary indexed condition, and to 3 interventions - of which Standard Brief Intervention is the first listed.
NCT00876941 reports a single indexed study location in Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00876941 about?
NCT00876941 is a clinical study titled "Assessing Screening Plus Brief Intervention's Resulting Efficacy (ASPIRE) to Stop Drug Use". The objective of this study is to test whether screening and brief intervention for drug use among primary care patients leads to improved drug-related outcomes (such as decreased drug use and consequences).
What is the current status of trial NCT00876941?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 589 participants. The study started on 2009-04. Estimated completion is 2014-09.
What conditions does trial NCT00876941 study?
This clinical trial studies the following conditions: Drug Abuse, Drug Dependence, Drug Usage.
What interventions are being tested in trial NCT00876941?
The interventions under investigation include: Standard Brief Intervention (BEHAVIORAL), Enhanced Brief Intervention (BEHAVIORAL), Control: Information and Feedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT00876941?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00876941 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Drug Abuse
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00876941's enrollment target sits among peer trials
589 4th of 21 higher than 18 of 21 other Drug Abuse trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Drug Abuse trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Medication Treatment for Opioid Use Disorder in Expectant Mothers
COMPLETED · Phase 3
-
Wakaya: Rising Up for Choctaw Youth Health
RECRUITING · NA
-
Suicidal Behavior in Patients Diagnosed With Bipolar Disorder
RECRUITING · NA
-
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
RECRUITING · NA
-
OUD Smartphone Services
ACTIVE NOT RECRUITING · NA
-
Adolescent Family-Based Alcohol Prevention
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01365169 · 590 participants · NA
Association Between Health Care Provider (HCP)-Assessed ECOG Performance Status (PS) and Overall Survival, and Objectively Measure of Physical Activity (PA) Levels in Advance-cancer Patients"
- NCT03774758 · 590 participants
Biomarkers for Risk Stratification in Lung Cancer
- NCT04747626 · 590 participants · NA
B-SAFER: Branched Stented Anastomosis Frozen Elephant Trunk Repair
- NCT05722938 · 590 participants · Phase 3
Efficacy and Safety of Trimodulin (BT588) in Subjects With Severe Community-acquired Pneumonia (sCAP)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia